US 11498963
Anti-LILRB antibodies and their use in detecting and treating cancer
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 11498963 (Anti-LILRB antibodies and their use in detecting and treating cancer) held by The Board of Regents of the University of Texas System expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P